Impel NeuroPharma Garners $12,000,000 Series B Financing

  • Feed Type
  • Date
  • Company Name
    Impel NeuroPharma
  • Mailing Address
    915 East Pine Street Seattle, WA 98122 USA
  • Company Description
    Impel NeuroPharma was founded with a mission to enable drugs to bypass the blood brain barrier. Co-founders Rodney Ho, Ph.D., John Hoekman, Ph.D., and Michael Hite began their work together in 2008 at the University of Washington, and developed a technical concept into an enabling, commercializable technology.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series B
  • Proceeds Purposes
    The company intends to use the funds to commercialize its technology.
  • M&A Terms
  • Venture Investor
    3M Corporation
  • Venture Investor

Trending on Xconomy